Yu Huang

发表

The Identification of Potential Biomarkers and Biological Pathways in Prostate Cancer

Q. Cao, H. Ruan, Zhengshuai Song, 2019, Journal of Cancer.

miR‐20a inhibits hypoxia‐induced autophagy by targeting ATG5/FIP200 in colorectal cancer

J. Zhao, Peng Zhang, Xianglin Yuan, 2019, Molecular carcinogenesis.

The Identification of Key Gene Expression Signature and Biological Pathways in Metastatic Renal Cell Carcinoma

Q. Cao, Zhengshuai Song, Ke Chen, 2020, Journal of Cancer.

Chemotherapy Increases the Risk of Developing Severe Illness in Breast Cancer Patients with COVID-19: A Multi-Center Retrospective Study in Hubei, China

Xu Wang, Ling Peng, Hua Yang, 2020 .

The Research Progress of PD-1/PD-L1 Inhibitors Enhancing Radiotherapy Efficacy

F. Tong, Rui-guang Zhang, Yu Huang, 2021, Frontiers in Oncology.

HIF2α Exerts Carcinogenesis in Clear Cell Renal Cell Carcinoma by Targeting High Expression of NUDT1 to Inhibit Oxidative Stress

Xiaoping Zhang, Hongmei Yang, Ke Chen, 2020 .

Efficacy and safety of recombinant human endostatin combined with whole-brain radiation therapy in patients with brain metastases from non-small cell lung cancer.

P. Yin, Xiaorong Dong, Yu Huang, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Programmed cell death 1 inhibitors with or without concurrent brain radiotherapy for lung cancer patients with brain metastases.

F. Tong, Huanhuan Li, Rui-guang Zhang, 2021, Annals of palliative medicine.

Downregulation of ubiquitin-specific protease 2 possesses prognostic and diagnostic value and promotes the clear cell renal cell carcinoma progression

Xiaoping Zhang, Hongmei Yang, Ke Chen, 2020, Annals of translational medicine.

Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study

Jun Yu Li, Gang Wu, Chaolin Huang, 2020, The Lancet Oncology.

The screening of pivotal gene expression signatures and biomarkers in renal carcinoma

Q. Cao, Sen Li, Zhengshuai Song, 2019, Journal of Cancer.

MMP9 and IGFBP1 Regulate Tumor Immune and Drive Tumor Progression in Clear Cell Renal Cell Carcinoma

Xiaoping Zhang, Ke Chen, Tianbo Xu, 2021, Journal of Cancer.

Combined treatment with PI 3 K inhibitor BKM 120 and PARP inhibitor olaparib is effective in inhibiting the gastric cancer cells with ARID 1 A deficiency

Guanghai Yang, Shunfang Liu, Yingjun Ding, 2018 .

High pretreatment neutrophil‐to‐lymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: Systematic review and meta‐analysis

G. Hu, Yu Huang, Yuhong Dai, 2018, Head & neck.

Combined inhibition of the EGFR and mTOR pathways in EGFR wild-type non-small cell lung cancer cell lines with different genetic backgrounds.

Shiying Yu, Q. Mei, S. Xia, 2013, Oncology reports.

mTORC1 inhibitor RAD001 (everolimus) enhances non-small cell lung cancer cell radiosensitivity in vitro via suppressing epithelial–mesenchymal transition

Yijun Tian, P. Peng, Weiheng Zhao, 2019, Acta Pharmacologica Sinica.

mTORC 1 inhibitor RAD 001 ( everolimus ) enhances non-small cell lung cancer cell radiosensitivity in vitro via suppressing epithelial – mesenchymal transition

Yijun Tian, P. Peng, Yuan Chen, 2019 .

Prognostic and clinicopathologic significance of neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma: evidence from a meta-analysis

Peng Zhang, Wei Sun, P. Peng, 2017, OncoTargets and therapy.

Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer

P. Peng, B. Ai, Yu Huang, 2016, Oncotarget.

Characteristics and outcomes of COVID-19 infection in 45 patients with breast cancer: A multi-center retrospective study in Hubei, China

Xu Wang, Ling Peng, Hua Yang, 2021, The Breast.

Restoring the epigenetically silenced PCK2 suppresses renal cell carcinoma progression and increases sensitivity to sunitinib by promoting endoplasmic reticulum stress

W. Xiong, Xiaoping Zhang, Hongmei Yang, 2020, Theranostics.

Increased ceramide production sensitizes breast cancer cell response to chemotherapy

Peng Zhang, Chuanrui Xu, Yu Huang, 2017, Cancer Chemotherapy and Pharmacology.

NNT‐induced tumor cell “slimming” reverses the pro‐carcinogenesis effect of HIF2a in tumors

W. Xiong, Xiaoping Zhang, Hongmei Yang, 2021, Clinical and translational medicine.

Identification of Key Differentially Expressed mRNAs, miRNAs, lncRNAs, and circRNAs for Xp11 Translocation Renal Cell Carcinoma (RCC) Based on Whole-Transcriptome Sequencing

D. Ni, M. Xiong, Zhaohui Chen, 2023, Genes.

Development and validation of a prognostic scale for hospitalized patients with terminally ill cancer in China

Shiying Yu, S. Xia, Yu Huang, 2013, Supportive Care in Cancer.

Induction of interleukin‐6 by irradiation and its role in epithelial mesenchymal transition and radioresistance of nasopharyngeal carcinoma cells

Wei Sun, Xun Yuan, G. Hu, 2020, Head & neck.

A dual mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal squamous cell carcinoma cells and sensitizes them to cisplatin

Shiying Yu, P. Peng, S. Xia, 2013, Anti-cancer drugs.

HIF2α promotes tumour growth in clear cell renal cell carcinoma by increasing the expression of NUDT1 to reduce oxidative stress

Xiaoping Zhang, Hongmei Yang, Huageng Liang, 2021, Clinical and translational medicine.

Prognostic and clinicopathological significance of platelet to lymphocyte ratio in esophageal cancer: a meta-analysis.

Peng Zhang, P. Peng, Yu Huang, 2018, Journal of thoracic disease.

Comprehensive analysis of the exosomal circRNA‐miRNA‐mRNA network in breast cancer

Shuangshuang Mao, H. Xiong, Chen Gong, 2023, The journal of gene medicine.

The influence of pemetrexed-based continuous maintenance therapy on survival of locally advanced and metastatic lung adenocarcinoma.

Gang Wu, Rui-guang Zhang, Ying Wang, 2019, Annals of translational medicine.

The Identification of Potential Biomarkers and Biological Pathways in Prostate Cancer

Q. Cao, Zhengshuai Song, Xiaoping Zhang, 2019, Journal of Cancer.

mTORC1 inhibitor RAD001 (everolimus) enhances non-small cell lung cancer cell radiosensitivity in vitro via suppressing epithelial–mesenchymal transition

Yijun Tian, P. Peng, Weiheng Zhao, 2019, Acta Pharmacologica Sinica.

Combined treatment with PI3K inhibitor BKM120 and PARP inhibitor olaparib is effective in inhibiting the gastric cancer cells with ARID1A deficiency.

Guanghai Yang, G. Hu, Shunfang Liu, 2018, Oncology reports.